@article{biolchi:pasteur-03265134, TITLE = {{Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates}}, AUTHOR = {Biolchi, Alessia and de Angelis, Gabriella and Moschioni, Monica and Tomei, Sara and Brunelli, Brunella and Giuliani, Maria and Bambini, Stefania and Borrow, Ray and Claus, Heike and Gorla, Maria Cecilia O and Hong, Eva and Lemos, Ana Paula S and Lucidarme, Jay and Taha, Muhamed-Kheir and Vogel, Ulrich and Comanducci, Maurizio and Budroni, Sonia and Giuliani, Marzia M and Rappuoli, Rino and Pizza, Mariagrazia and Boucher, Philip}, URL = {https://pasteur.hal.science/pasteur-03265134}, JOURNAL = {{Vaccine}}, PUBLISHER = {{Elsevier}}, VOLUME = {38}, NUMBER = {47}, PAGES = {7542 - 7550}, YEAR = {2020}, MONTH = Nov, DOI = {10.1016/j.vaccine.2020.09.050}, KEYWORDS = {4CMenB Meningococcal vaccine Non-MenB strains Cross-protection Serum bactericidal antibody activity Vaccine coverage list: 4CMenB ; four-component meningococcal serogroup B vaccine ; CFU ; colony forming units ; fHbp ; factor H binding protein ; hSBA ; serum bactericidal antibody assay using human complement ; IMD ; invasive meningococcal disease ; rLP2086 ; bivalent factor H binding protein vaccine ; MATS ; Meningococcal Antigen Typing System ; Men ; meningococcal serogroup ; MLST ; multilocus sequence typing ; NadA ; Neisseria adhesin A ; NHBA ; Neisserial heparin binding antigen ; OMV ; outer membrane vesicle ; PorA ; porin A ; SBA ; serum bactericidal antibody ; ST ; sequence type ; US ; United States ; 4CMenB ; Cross-protection ; Meningococcal vaccine ; Non-MenB strains ; Serum bactericidal antibody activity ; Vaccine coverage}, PDF = {https://pasteur.hal.science/pasteur-03265134/file/pmid33036804.pdf}, HAL_ID = {pasteur-03265134}, HAL_VERSION = {v1}, }